Fidelity Investments
BIOA

Fidelity Investments’s BioAge Labs BIOA Stock Holding History

Fidelity Investments’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.5M Sell
183,563
-6,735
-4% -$122K ﹤0.01% 2449
2026
Q1 		$3.33M Buy
190,298
+72,595
+62% +$1.4M ﹤0.01% 2445
2025
Q4 		$1.56M Buy
117,703
+26,585
+29% +$236K ﹤0.01% 2693
2025
Q3 		$536K Buy
91,118
+13,563
+17% +$63.5K ﹤0.01% 3005
2025
Q2 		$320K Buy
77,555
+5,248
+7% +$21.1K ﹤0.01% 3134
2025
Q1 		$272K Buy
72,307
+72,300
+1,032,857% +$334K ﹤0.01% 3134
2024
Q4 		$41 Buy
+7
New +$121 ﹤0.01% 5223

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Fidelity Investments's BIOA Position: Q2 2026 in Review

Fidelity Investments reduced its BioAge Labs (BIOA) stake by 3.5% in Q2 2026, selling an estimated $122K and leaving 183,563 shares worth $4.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Fidelity Investments first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Fidelity Investments held 183,563 shares of BioAge Labs worth $4.5M as of Q2 2026.
  • Fidelity Investments sold 6,735 BioAge Labs shares in Q2 2026, an estimated $122K.
  • BioAge Labs made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2449 holding.
  • Fidelity Investments first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.